Skip to content

Category

gene editing

1,701 papers

#gene editing Review Open access Sep 2026

Therapeutic reprogramming of natural killer cells for solid tumors: expanding frontiers into rare and ultra-rare malignancies

Progress in NK cell therapy across solid tumors provides a framework for extending increasingly adaptable and scalable immunotherapeutic platforms to rare and ultra-rare malignancies, with the potential to expand treatment opportunities for patient populations that have historically had limited therapeutic options.

F. Rosato, James W. Hodge · 0 citations
#gene editing Book Open access Sep 2026

Translational Cardiology in Genetic Cardiomyopathies

Translational cardiology applied to genetic cardiomyopathies is a rapidly evolving field that bridges molecular research and clinical practice through a “bench-to-bedside and back” paradigm. Hereditary cardiomyopathies, once classified primarily based on clinical phenotype, are now increasingly understood at the molecu...

Federico Angriman, Rebecca Artioli, Francesca Bortolotti et al. · 0 citations
#gene editing Review Open access Sep 2026

Biotechnological Advances and Multi‐Omics Insights for Fruit Quality, Postharvest Biology, and Genetic Improvement in Litchi ( Litchi chinensis Sonn.)

This review critically synthesizes current progress in litchi biotechnology, encompassing chromosome‐scale genome assembly, molecular marker systems, SNP resources, and functional genomics studies that have identified major regulatory genes and transcriptional networks associated with flowering, pigmentation, senescenc...

Ravi Kesari, Sareeta Nahakpam, Ruby Rani · 0 citations
#gene editing Open access Sep 2026

Bactomics HybAs v8.4-lite

This release is a major workflow upgrade from the legacy 8.4-lite Snakefile to a batch-capable, provenance-aware, benchmarked, validation-enabled, report-ready HybAs implementation. The new workflow preserves the core hybrid assembly logic while substantially improving execution control, reproducibility, taxonomic deci...

Jimi Goldstein · 0 citations
#gene editing Open access Sep 2026

Bactomics HybAs v8.4-lite

This release is a major workflow upgrade from the legacy 8.4-lite Snakefile to a batch-capable, provenance-aware, benchmarked, validation-enabled, report-ready HybAs implementation. The new workflow preserves the core hybrid assembly logic while substantially improving execution control, reproducibility, taxonomic deci...

Jimi Goldstein · 0 citations
#gene editing Open access Sep 2026

Morphological and biochemical evaluation of tolerance to water deficit identifies SlCLE9 as a novel regulator of drought stress

A screening to evaluate the responses to water deficit before the flowering stage uncovered new potential trait donors for breeding against drought stress and describes a novel role for SlCLE9 in drought tolerance in tomato.

M. Ekinci, Selda Ors Cirik, Hong Le et al. · 0 citations
#gene editing Book Open access Sep 2026

Arrhythmogenic Cardiomyopathy

Arrhythmogenic cardiomyopathy (ACM) is an inherited myocardial disease characterized by progressive fibro-fatty replacement of the ventricular myocardium, predisposing to ventricular arrhthmias, heart failure, and sudden cardiac death. Historically described as arrhythmogenic right ventricular cardiomyopathy (ARVC), AC...

Antonio De Luca, Chiara Cappelletto, Giulia Bassetto et al. · 0 citations
#gene editing Open access Sep 2026

CanProTarget

A residue-resolved prioritization platform for covalent cancer drug discovery. CanProTarget integrates cancer gene dependencies, small-molecule covalent ligand engagement measured by chemoproteomics, and base-editing evidence for individual cysteines, keeping each layer at the resolution it is measured at.

John-Paul Ong, Daniel Martins, Jean B. Bertoldo · 0 citations
#gene editing Review Open access Sep 2026

EDITING OUT CARDIOVASCULAR RISK: A NARRATIVE REVIEW OF GENE-EDITING APPROACHES TO PCSK9

Early clinical and preclinical evidence supports the feasibility of PCSK9 gene editing, and compares CRISPR-Cas9 nuclease knockout, base editing, and epigenetic silencing with established antibody and siRNA classes, focusing on efficacy, durability, and safety.

Piotr Bahyrycz, Karolina Markusiewicz, Magdalena Pyzik et al. · 0 citations
#gene editing Open access Sep 2026

Does adjusting for tumor proliferation bias prognostic gene expression estimates? Preregistered analysis code, decision rules and results

R analysis code, preregistered decision rules, result files, run logs and figures for a study of what omitting tumor proliferation does to prognostic gene expression estimates. For every expressed gene in a cohort, two Cox models are fitted for overall survival, one adjusted for age, sex and stage and one that adds a s...

Soon Woo Nam · 0 citations
#gene editing Dataset Open access Sep 2026

Supporting data for “Comparative Genomics in the genus Caenorhabditis and the Discovery of a Novel Toxin-Antidote System in C. elegans”

This dataset accompanies the thesis “Comparative Genomics in the genus Caenorhabditis and the Discovery of a Novel Toxin-Antidote System in C. elegans.” It contains 37 files documenting the comparative genomic analyses and experimental work presented in the thesis. Main and supplementary figures cover genetic mapping,...

Dongyao Liu, Chaogu Zheng · 0 citations

From tech blogs

See all →
Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.